Akita H - Search Results

1

Effects of neoadjuvant chemotherapy on primary tumor and lymph node metastasis in esophageal squamous cell carcinoma: additive association with prognosis.

Akita H, Doki Y, Yano M, Miyata H, Miyashiro I, Ohigashi H, Ishikawa O, Nishiyama A, Imaoka S. Akita H, et al. Dis Esophagus. 2009;22(4):291-7. doi: 10.1111/j.1442-2050.2008.00879.x. Epub 2008 Nov 19. Dis Esophagus. 2009. PMID: 19021686

2

Total removal of the posterior mediastinal gastric conduit due to gastric cancer after esophagectomy.

Akita H, Doki Y, Ishikawa O, Takachi K, Miyashiro I, Sasaki Y, Ohigashi H, Murata K, Noura S, Yamada T, Eguchi H, Imaoka S. Akita H, et al. J Surg Oncol. 2004 Mar 15;85(4):204-8. doi: 10.1002/jso.20017. J Surg Oncol. 2004. PMID: 14991878

3

[The evaluation of chemoradiotherapy to unresectable hepatobiliary cancers].

Akita H, Yamada T, Sasaki Y, Eguchi H, Ohigashi H, Ishikawa O, Imaoka S. Akita H, et al. Gan To Kagaku Ryoho. 2005 Oct;32(11):1727-9. Gan To Kagaku Ryoho. 2005. PMID: 16315922 Japanese.

4

Clinical significance of the second cycle response to cisplatin-based chemotherapy as preoperative treatment for esophageal squamous cell carcinoma.

Akita H, Doki Y, Miyata H, Hirao T, Yano M, Takachi K, Miyashiro I, Sasaki Y, Ishikawa O, Ohigashi H, Imaoka S. Akita H, et al. J Surg Oncol. 2006 Apr 1;93(5):401-9. doi: 10.1002/jso.20501. J Surg Oncol. 2006. PMID: 16550577

5

Real-time intraoperative assessment of residual liver functional reserve using pulse dye densitometry.

Akita H, Sasaki Y, Yamada T, Gotoh K, Ohigashi H, Eguchi H, Yano M, Ishikawa O, Imaoka S. Akita H, et al. World J Surg. 2008 Dec;32(12):2668-74. doi: 10.1007/s00268-008-9752-0. World J Surg. 2008. PMID: 18841411 Clinical Trial.

6

Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma.

Akita H, Zheng Z, Takeda Y, Kim C, Kittaka N, Kobayashi S, Marubashi S, Takemasa I, Nagano H, Dono K, Nakamori S, Monden M, Mori M, Doki Y, Bepler G. Akita H, et al. Oncogene. 2009 Aug 13;28(32):2903-9. doi: 10.1038/onc.2009.158. Epub 2009 Jun 22. Oncogene. 2009. PMID: 19543324 Free PMC article.

7

Abnormal expression of PFDN4 in colorectal cancer: a novel marker for prognosis.

Miyoshi N, Ishii H, Mimori K, Nishida N, Tokuoka M, Akita H, Sekimoto M, Doki Y, Mori M. Miyoshi N, et al. Among authors: akita h. Ann Surg Oncol. 2010 Nov;17(11):3030-6. doi: 10.1245/s10434-010-1138-5. Epub 2010 Jun 15. Ann Surg Oncol. 2010. PMID: 20552408

8

CD13 is a therapeutic target in human liver cancer stem cells.

Haraguchi N, Ishii H, Mimori K, Tanaka F, Ohkuma M, Kim HM, Akita H, Takiuchi D, Hatano H, Nagano H, Barnard GF, Doki Y, Mori M. Haraguchi N, et al. Among authors: akita h. J Clin Invest. 2010 Sep;120(9):3326-39. doi: 10.1172/JCI42550. Epub 2010 Aug 9. J Clin Invest. 2010. PMID: 20697159 Free PMC article.

9

Mural nodule in branch duct-type intraductal papillary mucinous neoplasms of the pancreas is a marker of malignant transformation and indication for surgery.

Akita H, Takeda Y, Hoshino H, Wada H, Kobayashi S, Marubashi S, Eguchi H, Tanemura M, Mori M, Doki Y, Nagano H. Akita H, et al. Am J Surg. 2011 Aug;202(2):214-9. doi: 10.1016/j.amjsurg.2010.06.020. Epub 2011 Mar 4. Am J Surg. 2011. PMID: 21376305

10

Ep-CAM is a significant prognostic factor in pancreatic cancer patients by suppressing cell activity.

Akita H, Nagano H, Takeda Y, Eguchi H, Wada H, Kobayashi S, Marubashi S, Tanemura M, Takahashi H, Ohigashi H, Tomita Y, Ishikawa O, Mori M, Doki Y. Akita H, et al. Oncogene. 2011 Aug 4;30(31):3468-76. doi: 10.1038/onc.2011.59. Epub 2011 Mar 14. Oncogene. 2011. PMID: 21399662

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,055 results

Search Page

Filters